Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).
Identifieur interne : 000410 ( Main/Exploration ); précédent : 000409; suivant : 000411Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).
Auteurs : Rodrigo Jiménez-García [Espagne] ; Cristina Rodríguez-Rieiro ; Valentín Hernández-Barrera ; Ana Lopez De Andres ; Agustin Rivero Cuadrado ; Angel Rodriguez Laso ; Pilar Carrasco-GarridoSource :
- Vaccine [ 1873-2518 ] ; 2011.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse multifactorielle (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Modèles logistiques (MeSH), Mâle (MeSH), Répartition par âge (MeSH), Sujet âgé (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- épidémiologie : Espagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Analyse multifactorielle, Femelle, Humains, Jeune adulte, Modèles logistiques, Mâle, Répartition par âge, Sujet âgé.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Distribution (MeSH), Aged (MeSH), Female (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Logistic Models (MeSH), Male (MeSH), Middle Aged (MeSH), Multivariate Analysis (MeSH), Spain (epidemiology), Vaccination (statistics & numerical data), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- Adolescent, Adult, Age Distribution, Aged, Female, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Young Adult.
Abstract
We aim to assess the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects. To do so, we describe and compare the influenza vaccination coverage in the 2006/2007 campaign between the Autonomous Community of Madrid (ACM), where in year 2005 the recommendation was extended by 5 years to cover all those aged 60 and over, and other regions of Spain where the universally recommended age was 65 years and above. We used individualized secondary data provided by two surveys carried out in 2007 in ACM and in the rest of Spain. The total number of subjects included in the study was 21,948. For the 60-64 years age group influenza vaccination coverage was significantly higher 40.1% (CI 95% 36.4-43.8) in ACM residents than among residents in the Rest of Spain 29.1% (CI 95% 24.5-33.7). The difference in vaccine uptake was even greater, 59% (CI 95% 51.8-66.2) vs. 43.5%(CI 95% 34.3-52.7), when we compared subjects who suffered a chronic condition, which represents an indication for the anti-influenza vaccination. The results of the multivariate analysis show that the probability of a subject aged 60-64 living in ACM of being vaccinated was almost two times higher (OR 1.95 CI 95% 1.46-2.61) than a person of the same age who lived in a region of Spain where the universal recommendation for influenza vaccine started at 65 years. In conclusion, the available evidence indicates the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects aged 60-64 years in our population.
DOI: 10.1016/j.vaccine.2011.02.004
PubMed: 21334388
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).</title><author><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name><affiliation wicri:level="2"><nlm:affiliation>Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón 28402 Madrid, Spain. rodrigo.jimenez@urjc.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón 28402 Madrid</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rodriguez Rieiro, Cristina" sort="Rodriguez Rieiro, Cristina" uniqKey="Rodriguez Rieiro C" first="Cristina" last="Rodríguez-Rieiro">Cristina Rodríguez-Rieiro</name></author><author><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name></author><author><name sortKey="Lopez De Andres, Ana" sort="Lopez De Andres, Ana" uniqKey="Lopez De Andres A" first="Ana" last="Lopez De Andres">Ana Lopez De Andres</name></author><author><name sortKey="Rivero Cuadrado, Agustin" sort="Rivero Cuadrado, Agustin" uniqKey="Rivero Cuadrado A" first="Agustin" last="Rivero Cuadrado">Agustin Rivero Cuadrado</name></author><author><name sortKey="Rodriguez Laso, Angel" sort="Rodriguez Laso, Angel" uniqKey="Rodriguez Laso A" first="Angel" last="Rodriguez Laso">Angel Rodriguez Laso</name></author><author><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21334388</idno><idno type="pmid">21334388</idno><idno type="doi">10.1016/j.vaccine.2011.02.004</idno><idno type="wicri:Area/Main/Corpus">00400</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00400</idno><idno type="wicri:Area/Main/Curation">000400</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000400</idno><idno type="wicri:Area/Main/Exploration">000400</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).</title><author><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name><affiliation wicri:level="2"><nlm:affiliation>Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón 28402 Madrid, Spain. rodrigo.jimenez@urjc.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón 28402 Madrid</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rodriguez Rieiro, Cristina" sort="Rodriguez Rieiro, Cristina" uniqKey="Rodriguez Rieiro C" first="Cristina" last="Rodríguez-Rieiro">Cristina Rodríguez-Rieiro</name></author><author><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name></author><author><name sortKey="Lopez De Andres, Ana" sort="Lopez De Andres, Ana" uniqKey="Lopez De Andres A" first="Ana" last="Lopez De Andres">Ana Lopez De Andres</name></author><author><name sortKey="Rivero Cuadrado, Agustin" sort="Rivero Cuadrado, Agustin" uniqKey="Rivero Cuadrado A" first="Agustin" last="Rivero Cuadrado">Agustin Rivero Cuadrado</name></author><author><name sortKey="Rodriguez Laso, Angel" sort="Rodriguez Laso, Angel" uniqKey="Rodriguez Laso A" first="Angel" last="Rodriguez Laso">Angel Rodriguez Laso</name></author><author><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Distribution (MeSH)</term><term>Aged (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Logistic Models (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Multivariate Analysis (MeSH)</term><term>Spain (epidemiology)</term><term>Vaccination (statistics & numerical data)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Analyse multifactorielle (MeSH)</term><term>Espagne (épidémiologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Modèles logistiques (MeSH)</term><term>Mâle (MeSH)</term><term>Répartition par âge (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Female</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse multifactorielle</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Modèles logistiques</term><term>Mâle</term><term>Répartition par âge</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We aim to assess the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects. To do so, we describe and compare the influenza vaccination coverage in the 2006/2007 campaign between the Autonomous Community of Madrid (ACM), where in year 2005 the recommendation was extended by 5 years to cover all those aged 60 and over, and other regions of Spain where the universally recommended age was 65 years and above. We used individualized secondary data provided by two surveys carried out in 2007 in ACM and in the rest of Spain. The total number of subjects included in the study was 21,948. For the 60-64 years age group influenza vaccination coverage was significantly higher 40.1% (CI 95% 36.4-43.8) in ACM residents than among residents in the Rest of Spain 29.1% (CI 95% 24.5-33.7). The difference in vaccine uptake was even greater, 59% (CI 95% 51.8-66.2) vs. 43.5%(CI 95% 34.3-52.7), when we compared subjects who suffered a chronic condition, which represents an indication for the anti-influenza vaccination. The results of the multivariate analysis show that the probability of a subject aged 60-64 living in ACM of being vaccinated was almost two times higher (OR 1.95 CI 95% 1.46-2.61) than a person of the same age who lived in a region of Spain where the universal recommendation for influenza vaccine started at 65 years. In conclusion, the available evidence indicates the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects aged 60-64 years in our population.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21334388</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2011</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>16</Issue><PubDate><Year>2011</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).</ArticleTitle><Pagination><MedlinePgn>2840-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2011.02.004</ELocationID><Abstract><AbstractText>We aim to assess the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects. To do so, we describe and compare the influenza vaccination coverage in the 2006/2007 campaign between the Autonomous Community of Madrid (ACM), where in year 2005 the recommendation was extended by 5 years to cover all those aged 60 and over, and other regions of Spain where the universally recommended age was 65 years and above. We used individualized secondary data provided by two surveys carried out in 2007 in ACM and in the rest of Spain. The total number of subjects included in the study was 21,948. For the 60-64 years age group influenza vaccination coverage was significantly higher 40.1% (CI 95% 36.4-43.8) in ACM residents than among residents in the Rest of Spain 29.1% (CI 95% 24.5-33.7). The difference in vaccine uptake was even greater, 59% (CI 95% 51.8-66.2) vs. 43.5%(CI 95% 34.3-52.7), when we compared subjects who suffered a chronic condition, which represents an indication for the anti-influenza vaccination. The results of the multivariate analysis show that the probability of a subject aged 60-64 living in ACM of being vaccinated was almost two times higher (OR 1.95 CI 95% 1.46-2.61) than a person of the same age who lived in a region of Spain where the universal recommendation for influenza vaccine started at 65 years. In conclusion, the available evidence indicates the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects aged 60-64 years in our population.</AbstractText><CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiménez-García</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón 28402 Madrid, Spain. rodrigo.jimenez@urjc.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez-Rieiro</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hernández-Barrera</LastName><ForeName>Valentín</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Lopez de Andres</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rivero Cuadrado</LastName><ForeName>Agustin</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rodriguez Laso</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Carrasco-Garrido</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="Y">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21334388</ArticleId><ArticleId IdType="pii">S0264-410X(11)00205-2</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2011.02.004</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region></list><tree><noCountry><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name><name sortKey="Lopez De Andres, Ana" sort="Lopez De Andres, Ana" uniqKey="Lopez De Andres A" first="Ana" last="Lopez De Andres">Ana Lopez De Andres</name><name sortKey="Rivero Cuadrado, Agustin" sort="Rivero Cuadrado, Agustin" uniqKey="Rivero Cuadrado A" first="Agustin" last="Rivero Cuadrado">Agustin Rivero Cuadrado</name><name sortKey="Rodriguez Laso, Angel" sort="Rodriguez Laso, Angel" uniqKey="Rodriguez Laso A" first="Angel" last="Rodriguez Laso">Angel Rodriguez Laso</name><name sortKey="Rodriguez Rieiro, Cristina" sort="Rodriguez Rieiro, Cristina" uniqKey="Rodriguez Rieiro C" first="Cristina" last="Rodríguez-Rieiro">Cristina Rodríguez-Rieiro</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000410 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000410 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21334388
|texte= Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21334388" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |